Covered recipient · General Payments record
ROBERT FERNANDEZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,367.49
- Reported across 191 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $695.58 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $258.58 | 14 |
| Lilly USA, LLC | $96.85 | 4 |
| PFIZER INC. | $90.98 | 5 |
| GlaxoSmithKline, LLC. | $69.40 | 3 |
| HARMONY BIOSCIENCES LLC | $59.02 | 3 |
| Merck Sharp & Dohme Corporation | $32.85 | 1 |
| ABIOMED | $24.19 | 1 |
| Amgen Inc. | $24.10 | 1 |
| DEXCOM, INC. | $20.95 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.31 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723104 | CMS |
| ABBVIE INC. | $12.54 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723106 | CMS |
| ABBVIE INC. | $13.73 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723108 | CMS |
| ABBVIE INC. | $13.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723110 | CMS |
| ABBVIE INC. | $20.70 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723112 | CMS |
| ABBVIE INC. | $13.98 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723114 | CMS |
| ABBVIE INC. | $30.68 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723116 | CMS |
| ABBVIE INC. | $32.75 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723118 | CMS |
| ABBVIE INC. | $21.33 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723120 | CMS |
| ABBVIE INC. | $11.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723122 | CMS |
| ABBVIE INC. | $26.98 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723124 | CMS |
| ABBVIE INC. | $16.14 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723126 | CMS |
| ABBVIE INC. | $12.71 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723128 | CMS |
| ABBVIE INC. | $4.10 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723130 | CMS |
| ABIOMED | $24.19 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142298179 | CMS |
| Amgen Inc. | $24.10 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115621877 | CMS |
| Dexcom, Inc. | $20.95 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331373 | CMS |
| GlaxoSmithKline, LLC. | $23.00 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116355793 | CMS |
| GlaxoSmithKline, LLC. | $28.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116254301 | CMS |
| GlaxoSmithKline, LLC. | $17.48 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116281002 | CMS |
| Harmony Biosciences Llc | $30.00 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141478408 | CMS |
| Harmony Biosciences Llc | $1.49 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141470242 | CMS |
| HARMONY BIOSCIENCES LLC | $27.53 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126057959 | CMS |
| Lilly USA, LLC | $24.04 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355192 | CMS |
| Lilly USA, LLC | $24.81 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367688 | CMS |
| Lilly USA, LLC | $33.36 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367690 | CMS |
| Lilly USA, LLC | $14.64 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135380210 | CMS |
| Merck Sharp & Dohme LLC | $32.85 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141572715 | CMS |
| PFIZER INC. | $18.80 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131119269 | CMS |
| PFIZER INC. | $18.25 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131632049 | CMS |
| PFIZER INC. | $19.16 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131962864 | CMS |
| PFIZER INC. | $14.45 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132117394 | CMS |
| PFIZER INC. | $20.32 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131115520 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.66 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151060783 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.